Clinical Trial Update: NAD+ Oral Supplement Pilot Intervention in Adult Females [NA]

View source ↗

Summary

A completed pilot trial evaluated an NAD+ oral supplement in adult females for cognitive change and inflammation, with potential relevance to neurodegenerative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Inflammation
• Neurodegenerative Diseases

Drugs mentioned

• NAD+ oral supplement (nicotinamide adenine dinucleotide)

Snippet

Sponsor: University of Rhode Island | Conditions: Cognitive Change, Inflammation | NA | Status: COMPLETED